Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat

Learning and Memory

Volumn 17, Issue 10, 2010, Pages 502-511

  Goonawardena, Anushka V ^a   Robinson, Lianne ^b   Hampson, Robert E ^a,b   Riedel, Gernot ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID 1 RECEPTOR; DIZOCILPINE; RIVASTIGMINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SINGLE UNIT ACTIVITY; TASK PERFORMANCE;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; BENZOXAZINES; CANNABINOIDS; CHOLINESTERASE INHIBITORS; HIPPOCAMPUS; MEMORY, SHORT-TERM; MORPHOLINES; NAPHTHALENES; PHENYLCARBAMATES; RATS; RECEPTOR CROSS-TALK; RECEPTOR, CANNABINOID, CB1;

EID: 78649597251     PISSN: 10720502     EISSN: 15495485     Source Type: Journal    
DOI: 10.1101/lm.1893710     Document Type: Article

References (50)

1. Acquas E, Pisanu A, Marrocu P, Di Chiara G. 2000. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur J Pharmacol 401: 179-185.
2. 9-Tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: A microdialysis study. Eur J Pharmacol 419: 155-161.
3. Beatty WW, Butters N, Janowsky DS. 1986. Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia. Behav Neural Biol 45: 196-211.
4. Bejar C, Wang RH, Weinstock M. 1999. Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 383: 231-240.
5. Braida D, Sala M. 2000. Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. Neuroreport 11: 2025-2029.
6. 9-tetrahydrocannabinol in rats. Brain Res 809: 1-4.
7. Deadwyler SA, Bunn T, Hampson RE. 1996. Hippocampal ensemble activity during spatial delayed-nonmatch-to-sample performance in rats. J Neurosci 16: 354-372.
8. Deiana S, Harrington CR, Wischik CM, Riedel G. 2009. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: Comparison with rivastigmine. Psychopharmacology 202: 53-65.
9. 9-tetrahydrocannabinol: Search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res 952: 239-245.
10. Fitz NF, Gibbs RB, Johnson DA. 2008. Selective lesion of septal cholinergic neurons in rats impairs acquisition of a delayed matching to position T-maze task by delaying the shift from a response to a place strategy. Brain Res Bull 77: 356-360.
11. Gessa GL, Mascia MS, Casu MA, Carta G. 1997. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A. Eur J Pharmacol 327: R1-R2.
12. Gessa GL, Casu MA, Carta G, Mascia MS. 1998. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR141716A. Eur J Pharmacol 355: 119-124.
13. Gifford AN, Ashby CR Jr. 1996. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther 277: 1431-1436.
14. Gifford AN, Samiian L, Gatley SJ, Ashby CR Jr. 1997a. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices. Eur J Pharmacol 324: 187-192.
15. Gifford AN, Tang Y, Gatley SJ, Volkow ND, Lan R, Makriyannis A. 1997b. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci Lett 238: 84-86.
16. Gifford AN, Bruneus M, Gatley SJ, Volkow ND. 2000. Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes. Br J Pharmacol 131: 645-650.
17. Goonawardena AV, Robinson L, Riedel G, Hampson RE. 2009. Recruitment of hippocampal neurons to encode behavioral events in the rat: Alterations in cognitive demand and cannabinoid exposure. Hippocampus (in press). doi: 10.1002/hipo.20706.
18. Goonawardena AV, Riedel G, Hampson RE. 2010. Cannabinoids alter spontaneous firing, bursting and cell synchrony of hippocampal principal cells. Hippocampus (in press). doi:10.1002/hipo.20769.
19. Hampson RE, Deadwyler SA. 1998. Role of cannabinoid receptors in memory storage. Neurobiol Dis 5: 474-482.
20. Hampson RE, Deadwyler SA. 1999. Cannabinoids, hippocampal function and memory. Life Sci 65: 715-723.
21. Hampson RE, Deadwyler SA. 2000. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20: 8932-8942.
22. Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA. 2003. Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus 13: 543-556.
23. Harkany T, Hartig W, Berghuis P, Dobszay MB, Zilberter Y, Edwards RH, Mackie K, Ernfors P. 2003. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons. Eur J Neurosci 18: 1979-1992.
24. Harkany T, Dobszay MB, Cayetanot F, Hartig W, Siegemund T, Aujard F, Mackie K. 2005. Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: A comparison between the gray mouse lemur (Microcebus murinus, primates) and rat. Neuroscience 135: 595-609.
25. 9- tetrahydrocannabinol on delayed match to sample performance in rats: Alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 264: 294-307.
26. Hironaka N, Ando K. 1996. Effects of cholinergic drugs on scopolamine-induced memory impairment in rhesus monkeys. Nihon Shinkei Seishin Yakurigaku Zasshi 16: 103-108.
27. Kathmann M, Weber B, Schlicker E. 2001a. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice. Naunyn Schmiedebergs Arch Pharmacol 363: 50-56.
28. Kathmann M, Weber B, Zimmer A, Schlicker E. 2001b. Enhanced acetylcholine release in the hippocampus of cannabinoid CB(1) receptor-deficient mice. Br J Pharmacol 132: 1169-1173.
29. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558.
30. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF. 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
31. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M, Ohno-Shosaku T, Kano M. 2006. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26: 2991-3001.
32. Lichtman AH, Martin BR. 1996. D9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126: 125-131.
33. Lichtman AH, Dimen KR, Martin BR. 1995. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119: 282-290.
34. 9- tetrahydrocannabinol-induced impairment of spatial memory in the eight-arm radial maze. Life Sci 72: 397-407.
35. Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, et al. 2006. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51: 455-466.
36. 9- tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Neuropharmacology 41: 392-399.
37. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th ed. Academic Press, New York.
38. Riedel G, Davies SN. 2005. Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol 168: 445-477.
39. Riedel G, Platt B. 2004. From messengers to molecules: Memories are made of these. Kluwer, New York.
40. Riedel G, Platt B, Micheau J. 2003. Glutamate receptor function in learning and memory. Behav Brain Res 140: 1-47.
41. Robinson L, Riedel G. 2004. Cannabinoid function in spatial learning: An update. Curr Neuropharmacol 2: 125-143.
42. Robinson L, Goonawardena AV, Pertwee RG, Hampson RE, Riedel G. 2007. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. Br J Pharmacol 151: 688-700.
43. Robinson L, Goonawardena AV, Pertwee RG, Hampson RE, Platt B, Riedel G. 2010. WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res 208: 584-592.
44. Sullivan JM. 1999. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J Neurophysiol 8: 1286-1294.
45. Takahashi KA, Castillo PE. 2006. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139: 795-802.
46. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, Soubrie P. 1996. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology (Berl) 126: 165-172.
47. Thomas E, Snyder PJ, Pietrzak RH, Jackson CE, Bednar M, Maruff P. 2008. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. Neuropsychologia 46: 2476-2484.
48. Tsou K, Mackie K, Sanudo-Pena MC, Walker JM. 1999. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93: 969-975.
49. Tzavara ET, Wade M, Nomikos GG. 2003. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: Site and mechanism of action. J Neurosci 23: 9374-9384.
50. Wang RH, Bejar C, Weinstock M. 2000. Gender differences in the effect of rivastigmineon brain cholinesterase activity and cognitive function in rats. Neuropharmacology 39: 497-506.